HONG KONG – Chinese biopharmaceutical firm Beigene Ltd. filed with the Hong Kong Stock Exchange (HKEX) for a monster IPO that could raise more than $1 billion. It is the second biotech firm to seek an …
( read original story …)
The HongKong News
HONG KONG – Chinese biopharmaceutical firm Beigene Ltd. filed with the Hong Kong Stock Exchange (HKEX) for a monster IPO that could raise more than $1 billion. It is the second biotech firm to seek an …
( read original story …)